These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10418897)

  • 1. Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine.
    Rimmelzwaan GF; Baars M; van Beek R; de Lijster P; de Jong JC; Claas EC; Osterhaus AD
    Vaccine; 1999 Jun; 17(20-21):2512-6. PubMed ID: 10418897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses.
    Rimmelzwaan GF; Baars M; van Amerongen G; van Beek R; Osterhaus AD
    Vaccine; 2001 Oct; 20(1-2):158-63. PubMed ID: 11567760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the quality of protection induced by a porcine influenza A vaccine to challenge with an H3N2 virus.
    Heinen PP; van Nieuwstadt AP; de Boer-Luijtze EA; Bianchi AT
    Vet Immunol Immunopathol; 2001 Sep; 82(1-2):39-56. PubMed ID: 11557293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (report to the Medical Research Council's Sub-Committee on influenza Vaccines (CDVIP/IV)).
    Potter CW; Jennings R; Ali MJ; Wood JM; Dunleavy U; Tyrrell DA
    Epidemiol Infect; 1987 Oct; 99(2):501-15. PubMed ID: 3315713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines.
    Rimmelzwaan GF; Baars M; van Beek R; van Amerongen G; Lövgren-Bengtsson K; Claas EC; Osterhaus AD
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():757-65. PubMed ID: 9129647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay.
    Li ZN; Liu F; Gross FL; Kim L; Ferdinands J; Carney P; Chang J; Stevens J; Tumpey T; Levine MZ
    mBio; 2021 Feb; 12(1):. PubMed ID: 33531397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications for Seasonal Vaccine Strain Selection and Vaccine Performance.
    Kosikova M; Li L; Radvak P; Ye Z; Wan XF; Xie H
    Clin Infect Dis; 2018 Oct; 67(10):1523-1532. PubMed ID: 29672713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus ISCOMs: antibody response in animals.
    Sundquist B; Lövgren K; Morein B
    Vaccine; 1988 Feb; 6(1):49-53. PubMed ID: 3354258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults.
    Antonen JA; Pyhälä R; Hannula PM; Ala-Houhala IO; Santanen R; Ikonen N; Saha HH
    Nephrol Dial Transplant; 2003 Apr; 18(4):777-81. PubMed ID: 12637648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets.
    Hay JA; Laurie K; White M; Riley S
    PLoS Comput Biol; 2019 Aug; 15(8):e1007294. PubMed ID: 31425503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines.
    Mumford JA; Jessett D; Dunleavy U; Wood J; Hannant D; Sundquist B; Cook RF
    Vaccine; 1994 Jul; 12(9):857-63. PubMed ID: 7975864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys.
    Mizuno D; Kimoto T; Sakai S; Takahashi E; Kim H; Kido H
    Vaccine; 2016 Apr; 34(16):1881-8. PubMed ID: 26954466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants.
    Wong SS; Duan S; DeBeauchamp J; Zanin M; Kercher L; Sonnberg S; Fabrizio T; Jeevan T; Crumpton JC; Oshansky C; Sun Y; Tang L; Thomas P; Webby R
    Sci Rep; 2017 Mar; 7():44727. PubMed ID: 28303960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination.
    Petersson P; Hedenskog M; Alves D; Brytting M; Schröder U; Linde A; Lundkvist A
    Vaccine; 2010 Sep; 28(39):6491-7. PubMed ID: 20637767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
    Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.